| Product Code: ETC7657168 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Shubham Padhi | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Israel Non-Invasive Cancer Diagnostics Market Overview |
3.1 Israel Country Macro Economic Indicators |
3.2 Israel Non-Invasive Cancer Diagnostics Market Revenues & Volume, 2021 & 2031F |
3.3 Israel Non-Invasive Cancer Diagnostics Market - Industry Life Cycle |
3.4 Israel Non-Invasive Cancer Diagnostics Market - Porter's Five Forces |
3.5 Israel Non-Invasive Cancer Diagnostics Market Revenues & Volume Share, By Test Type, 2021 & 2031F |
3.6 Israel Non-Invasive Cancer Diagnostics Market Revenues & Volume Share, By Cancer Type, 2021 & 2031F |
3.7 Israel Non-Invasive Cancer Diagnostics Market Revenues & Volume Share, By End-user, 2021 & 2031F |
4 Israel Non-Invasive Cancer Diagnostics Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of cancer in Israel |
4.2.2 Growing adoption of non-invasive diagnostic techniques |
4.2.3 Technological advancements in cancer diagnostics |
4.3 Market Restraints |
4.3.1 Stringent regulatory requirements for non-invasive diagnostics |
4.3.2 High cost associated with non-invasive cancer diagnostics |
5 Israel Non-Invasive Cancer Diagnostics Market Trends |
6 Israel Non-Invasive Cancer Diagnostics Market, By Types |
6.1 Israel Non-Invasive Cancer Diagnostics Market, By Test Type |
6.1.1 Overview and Analysis |
6.1.2 Israel Non-Invasive Cancer Diagnostics Market Revenues & Volume, By Test Type, 2021- 2031F |
6.1.3 Israel Non-Invasive Cancer Diagnostics Market Revenues & Volume, By Urine Test, 2021- 2031F |
6.1.4 Israel Non-Invasive Cancer Diagnostics Market Revenues & Volume, By Imaging Test, 2021- 2031F |
6.1.5 Israel Non-Invasive Cancer Diagnostics Market Revenues & Volume, By Spectroscopy, 2021- 2031F |
6.2 Israel Non-Invasive Cancer Diagnostics Market, By Cancer Type |
6.2.1 Overview and Analysis |
6.2.2 Israel Non-Invasive Cancer Diagnostics Market Revenues & Volume, By Breast Cancer, 2021- 2031F |
6.2.3 Israel Non-Invasive Cancer Diagnostics Market Revenues & Volume, By Lung Cancer, 2021- 2031F |
6.2.4 Israel Non-Invasive Cancer Diagnostics Market Revenues & Volume, By Blood Cancer, 2021- 2031F |
6.2.5 Israel Non-Invasive Cancer Diagnostics Market Revenues & Volume, By Ovarian Cancer, 2021- 2031F |
6.2.6 Israel Non-Invasive Cancer Diagnostics Market Revenues & Volume, By Colorectal Cancer, 2021- 2031F |
6.2.7 Israel Non-Invasive Cancer Diagnostics Market Revenues & Volume, By Others, 2021- 2031F |
6.3 Israel Non-Invasive Cancer Diagnostics Market, By End-user |
6.3.1 Overview and Analysis |
6.3.2 Israel Non-Invasive Cancer Diagnostics Market Revenues & Volume, By Hospitals & Clinics, 2021- 2031F |
6.3.3 Israel Non-Invasive Cancer Diagnostics Market Revenues & Volume, By Ambulatory Care, 2021- 2031F |
6.3.4 Israel Non-Invasive Cancer Diagnostics Market Revenues & Volume, By Others, 2021- 2031F |
7 Israel Non-Invasive Cancer Diagnostics Market Import-Export Trade Statistics |
7.1 Israel Non-Invasive Cancer Diagnostics Market Export to Major Countries |
7.2 Israel Non-Invasive Cancer Diagnostics Market Imports from Major Countries |
8 Israel Non-Invasive Cancer Diagnostics Market Key Performance Indicators |
8.1 Adoption rate of non-invasive diagnostic techniques in cancer screening |
8.2 Number of research and development collaborations for enhancing non-invasive diagnostic technologies |
8.3 Rate of integration of artificial intelligence and machine learning in cancer diagnostics |
8.4 Number of clinical trials utilizing non-invasive cancer diagnostics |
8.5 Patient satisfaction and acceptance rates of non-invasive diagnostic procedures |
9 Israel Non-Invasive Cancer Diagnostics Market - Opportunity Assessment |
9.1 Israel Non-Invasive Cancer Diagnostics Market Opportunity Assessment, By Test Type, 2021 & 2031F |
9.2 Israel Non-Invasive Cancer Diagnostics Market Opportunity Assessment, By Cancer Type, 2021 & 2031F |
9.3 Israel Non-Invasive Cancer Diagnostics Market Opportunity Assessment, By End-user, 2021 & 2031F |
10 Israel Non-Invasive Cancer Diagnostics Market - Competitive Landscape |
10.1 Israel Non-Invasive Cancer Diagnostics Market Revenue Share, By Companies, 2024 |
10.2 Israel Non-Invasive Cancer Diagnostics Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here